Literature DB >> 30874958

Contemporary Treatment of Locally Advanced Oral Cancer.

David Kim1, Ryan Li2.   

Abstract

OPINION STATEMENT: At our institution, locally advanced oral cancer is most commonly treated with surgical resection, immediate reconstruction, and adjuvant radiotherapy with or without concurrent systemic therapy depending on final surgical pathologic analysis. There are patients with markedly advanced local or regional disease who unfortunately will have a low probability of cure. We counsel these patients on induction chemotherapy, emphasizing that this is unlikely to result in a smaller volume of surgical resection. In these patients, a good response to induction chemotherapy is more frequently followed by concurrent chemoradiotherapy. We have not been in the practice of commonly recommending definitive chemoradiotherapy for locally advanced oral cancer when upfront surgery is an option. However, as reviewed below, there is a significant rationale for definitive chemoradiotherapy in patients who are surgical candidates, with the hope of good oncologic outcomes, and potential functional organ preservation. The experts who report their experiences in the studies reviewed below provide a strong argument for considering this approach.

Entities:  

Keywords:  Immunotherapy; Neoadjuvant therapy; Oral cavity squamous cell carcinoma; Outcome; Primary chemoradiotherapy; Treatment

Year:  2019        PMID: 30874958     DOI: 10.1007/s11864-019-0631-8

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  29 in total

1.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

2.  Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue.

Authors:  J N Myers; J S Greenberg; V Mo; D Roberts
Journal:  Cancer       Date:  2001-12-15       Impact factor: 6.860

3.  Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.

Authors:  David J Sher; Vijaya Thotakura; Tracy A Balboni; Charles M Norris; Robert I Haddad; Marshall R Posner; Jochen Lorch; Laura A Goguen; Donald J Annino; Roy B Tishler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-29       Impact factor: 7.038

4.  Swallowing function in patients with head and neck cancer prior to treatment.

Authors:  K M Stenson; E MacCracken; M List; D J Haraf; B Brockstein; R Weichselbaum; E E Vokes
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-03

5.  Primary chemoradiotherapy for oral cavity squamous cell carcinoma.

Authors:  Anthony K Crombie; Camile Farah; Lee Tripcony; Graeme Dickie; Martin D Batstone
Journal:  Oral Oncol       Date:  2012-04-18       Impact factor: 5.337

6.  Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.

Authors:  Mark W Lingen; Weihong Xiao; Alessandra Schmitt; Bo Jiang; Robert Pickard; Paul Kreinbrink; Bayardo Perez-Ordonez; Richard C Jordan; Maura L Gillison
Journal:  Oral Oncol       Date:  2012-07-28       Impact factor: 5.337

7.  Never-smokers, never-drinkers: unique clinical subgroup of young patients with head and neck squamous cell cancers.

Authors:  Stephen L Harris; Randall J Kimple; D Neil Hayes; Marion E Couch; Julian G Rosenman
Journal:  Head Neck       Date:  2010-04       Impact factor: 3.147

8.  Chemoradiation for patients with advanced oral cavity cancer.

Authors:  Kerstin M Stenson; Rangesh Kunnavakkam; Ezra E W Cohen; Louis D Portugal; Elizabeth Blair; Daniel J Haraf; Joseph Salama; Everett E Vokes
Journal:  Laryngoscope       Date:  2010-01       Impact factor: 3.325

9.  Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.

Authors:  Ezra E W Cohen; Joshua Baru; Dezheng Huo; Daniel J Haraf; Maureen Crowley; Mary Ellyn Witt; Elizabeth A Blair; Ralph R Weichselbaum; Fred Rosen; Everett E Vokes; Kerstin Stenson
Journal:  Head Neck       Date:  2009-08       Impact factor: 3.147

10.  Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison.

Authors:  K-C Soo; E-H Tan; J Wee; D Lim; B-C Tai; M-L Khoo; C Goh; S-S Leong; T Tan; K-W Fong; P Lu; A See; D Machin
Journal:  Br J Cancer       Date:  2005-08-08       Impact factor: 7.640

View more
  9 in total

1.  Epigenetic Deregulation of Protein Tyrosine Kinase 6 Promotes Carcinogenesis of Oral Squamous Cell Carcinoma.

Authors:  Yi-Ping Hsieh; Ken-Chung Chen; Meng-Yen Chen; Ling-Yu Huang; An-Yu Su; Wei-Fan Chiang; Wen-Tsung Huang; Tze-Ta Huang
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

2.  Single-Cell RNA Sequencing Analysis for Oncogenic Mechanisms Underlying Oral Squamous Cell Carcinoma Carcinogenesis with Candida albicans Infection.

Authors:  Yi-Ping Hsieh; Yu-Hsueh Wu; Siao-Muk Cheng; Fang-Kuei Lin; Daw-Yang Hwang; Shih-Sheng Jiang; Ken-Chung Chen; Meng-Yen Chen; Wei-Fan Chiang; Ko-Jiunn Liu; Nam Cong-Nhat Huynh; Wen-Tsung Huang; Tze-Ta Huang
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

3.  Focused ultrasound ablation of a large canine oral tumor achieves efficient tumor remission: a case report.

Authors:  Ashish Ranjan; Deepan Kishore; Harshini Ashar; Tina Neel; Akansha Singh; Sunil More
Journal:  Int J Hyperthermia       Date:  2021       Impact factor: 3.914

4.  Silencing of LncRNA AFAP1-AS1 Inhibits Cell Proliferation in Oral Squamous Cancer by Suppressing CCNA2.

Authors:  Tao Li; Duanqin Liu; Chenglong Li; Lu Ru; Xuixia Wang
Journal:  Cancer Manag Res       Date:  2021-10-15       Impact factor: 3.989

Review 5.  Robotic and Microrobotic Tools for Dental Therapy.

Authors:  Chen Cheng; Xue Yinan; Xie Zongxin; Shi Lei; Xue Yanan; Yang Yanli
Journal:  J Healthc Eng       Date:  2022-02-18       Impact factor: 2.682

6.  Possible Action of Olaparib for Preventing Invasion of Oral Squamous Cell Carcinoma In Vitro and In Vivo.

Authors:  Nanami Nakamura; Hisako Fujihara; Koji Kawaguchi; Hiroyuki Yamada; Ryoko Nakayama; Masaaki Yasukawa; Yuta Kishi; Yoshiki Hamada; Mitsuko Masutani
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

7.  Analysis of Intervention Effect and Satisfaction of Holistic Nursing after Oral Tumor Resection.

Authors:  Lingling Qu; Yan Yin; Na Zhao; Yongmei Lv; Hangyong Xu
Journal:  Comput Math Methods Med       Date:  2022-07-15       Impact factor: 2.809

8.  Clinical efficacy of highly agglutinative staphylococcin combined with neoadjuvant chemotherapy on patients with intermediate or advanced oral cancer.

Authors:  Nan Guo; Gengbing Lin; Xie Shi
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

9.  Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.

Authors:  Ming Li; Feng Gao; Xinfang Yu; Qing Zhao; Li Zhou; Wenbin Liu; Wei Li
Journal:  J Exp Clin Cancer Res       Date:  2020-05-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.